These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1387463)

  • 21. Frontal and parietal metabolic disturbances in unipolar depression.
    Biver F; Goldman S; Delvenne V; Luxen A; De Maertelaer V; Hubain P; Mendlewicz J; Lotstra F
    Biol Psychiatry; 1994 Sep; 36(6):381-8. PubMed ID: 7803599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients.
    Adams KM; Gilman S; Koeppe RA; Kluin KJ; Brunberg JA; Dede D; Berent S; Kroll PD
    Alcohol Clin Exp Res; 1993 Apr; 17(2):205-10. PubMed ID: 8488956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
    Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
    N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.
    Brooks JO; Wang PW; Bonner JC; Rosen AC; Hoblyn JC; Hill SJ; Ketter TA
    J Psychiatr Res; 2009 Jan; 43(3):181-8. PubMed ID: 18582900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
    Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
    J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
    Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
    Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.
    Roelcke U; Kappos L; Lechner-Scott J; Brunnschweiler H; Huber S; Ammann W; Plohmann A; Dellas S; Maguire RP; Missimer J; Radü EW; Steck A; Leenders KL
    Neurology; 1997 Jun; 48(6):1566-71. PubMed ID: 9191767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional cerebral glucose metabolism in bulimia nervosa.
    Andreason PJ; Altemus M; Zametkin AJ; King AC; Lucinio J; Cohen RM
    Am J Psychiatry; 1992 Nov; 149(11):1506-13. PubMed ID: 1415817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.
    De Volder AG; Francart J; Laterre C; Dooms G; Bol A; Michel C; Goffinet AM
    Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left prefrontal glucose hypometabolism in the depressed state: a confirmation.
    Martinot JL; Hardy P; Feline A; Huret JD; Mazoyer B; Attar-Levy D; Pappata S; Syrota A
    Am J Psychiatry; 1990 Oct; 147(10):1313-7. PubMed ID: 2399999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontal lobe hypometabolism and depression in Alzheimer's disease.
    Hirono N; Mori E; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
    Neurology; 1998 Feb; 50(2):380-3. PubMed ID: 9484357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
    Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
    Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia.
    Karbe H; Holthoff VA; Rudolf J; Herholz K; Heiss WD
    Neurology; 1992 Aug; 42(8):1540-4. PubMed ID: 1641150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral glucose and dopa metabolism in movement disorders.
    Martin WR; Hayden MR
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):448-51. PubMed ID: 2960430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of prefrontal cortex glucose metabolism common to three types of depression.
    Baxter LR; Schwartz JM; Phelps ME; Mazziotta JC; Guze BH; Selin CE; Gerner RH; Sumida RM
    Arch Gen Psychiatry; 1989 Mar; 46(3):243-50. PubMed ID: 2784046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.